APA (7th ed.) Citation

Laack, E., Scheffler, A., Burkholder, I., Boeters, I., Andritzky, B., Schuch, G., . . . Hossfeld, D. K. (2005). Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer (01695002), 50(1), 51. https://doi.org/10.1016/j.lungcan.2005.05.011

Chicago Style (17th ed.) Citation

Laack, Eckart, et al. "Pretreatment Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase-9 (MMP-9) Serum Levels in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC)." Lung Cancer (01695002) 50, no. 1 (2005): 51. https://doi.org/10.1016/j.lungcan.2005.05.011.

MLA (9th ed.) Citation

Laack, Eckart, et al. "Pretreatment Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase-9 (MMP-9) Serum Levels in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC)." Lung Cancer (01695002), vol. 50, no. 1, 2005, p. 51, https://doi.org/10.1016/j.lungcan.2005.05.011.